Risperidone depot in the treatment of psychosis associated with multiple sclerosis -- a case report

J Psychopharmacol. 2008 Nov;22(8):925-6. doi: 10.1177/0269881107083997. Epub 2008 Feb 28.

Abstract

There is insufficient evidence worldwide regarding the choice of an appropriate anti-psychotic agent in the treatment of psychosis associated with multiple sclerosis. This case report demonstrates the effective use of Risperidone depot.

Publication types

  • Case Reports

MeSH terms

  • Antipsychotic Agents / administration & dosage*
  • Delayed-Action Preparations
  • Female
  • Humans
  • Middle Aged
  • Multiple Sclerosis / complications*
  • Psychotic Disorders / drug therapy*
  • Risperidone / administration & dosage*

Substances

  • Antipsychotic Agents
  • Delayed-Action Preparations
  • Risperidone